Given that the role of Keap1-Nrf2 signaling in cancers is more commonly investigated by using loss-of-function mutants of KEAP1 (Wu and Papagiannakopoulos, 2020), the role of its wildtype protein in regulating tumor cell behavior remains largely unexplored. This evidence concerns the gene KEAP1 and cancer.